Dynamic risk assessment in patients with differentiated thyroid cancer

被引:0
|
作者
Abelleira, Erika [1 ]
Jerkovich, Fernando [1 ]
机构
[1] Univ Buenos Aires, Hosp Clin Jose San Martin UBA, Div Endocrinol, Cordoba 2351,5th floor, RA-1120 Cordoba, Buenos Aires, Argentina
关键词
Dynamic risk assessment; Risk of recurrence; Differentiated thyroid cancer; Thyroid cancer; CLINICALLY SIGNIFICANT DISEASE; RADIOIODINE REMNANT ABLATION; FALSE-POSITIVE ABNORMALITIES; RADIOACTIVE IODINE THERAPY; SERIAL NECK ULTRASOUND; QUALITY-OF-LIFE; ACTIVE SURVEILLANCE; PAPILLARY MICROCARCINOMA; STRATIFICATION SYSTEM; MANAGEMENT GUIDELINES;
D O I
10.1007/s11154-023-09857-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The current approach for patients with differentiated thyroid carcinoma should be individualized according to the risk of recurrence, and this stratification could be used to identify the risk of persistent/recurrent disease in three scenarios: preoperatively, immediately postoperatively, and during long-term follow-up. The initial risk of recurrence will tailor the management of the patient in the preoperative and immediate postoperative settings, while the dynamic risk, which considers the responses to treatment, could guide the decision-making process for remnant ablation and long-term management.This review provides a summary of the existing information regarding the dynamic risk of recurrence and recommended management for patients with differentiated thyroid cancer. The application of this approach is essential to avoid unnecessary treatments for most patients who will have a favorable prognosis. On the other hand, it allows specific therapeutic interventions for those patients at high risk of recurrence. In the future, analysis of tumor biology and prospective studies will surely improve the accuracy of recurrence risk prediction.
引用
收藏
页码:79 / 93
页数:15
相关论文
共 50 条
  • [21] Thyroglobulin levels before radioactive iodine therapy and dynamic risk stratification after 1 year in patients with differentiated thyroid cancer
    Bandeira, Leonardo
    Padovani, Rosalia do Prado
    Ticly, Ana Luiza
    Cury, Adriano Namo
    Scalissi, Nilza Maria
    Silveira Marone, Marilia Martins
    Ferraz, Carolina
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (06): : 590 - 599
  • [22] Lobectomy in patients with differentiated thyroid cancer: experience of a Chilean tertiary center
    Fuentes, Ignacio
    Santana, Roberto
    Espinoza, Martin
    Arteaga, Eugenio
    Uslar, Thomas
    Baudrand, Rene
    Gonzalez, Gilberto
    Guarda, Francisco J.
    Lustig, Nicole
    Mosso, Lorena
    Nilo, Flavia
    Valenzuela, Felipe
    Dominguez, Francisco
    Gonzalez, Hernan Eugenio
    Montero, Pablo H.
    Cruz, Francisco
    Solar, Antonieta
    Dominguez, Jose M.
    ENDOCRINE, 2024, 86 (02) : 692 - 698
  • [23] Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer
    Pitoia, Fabian
    Jerkovich, Fernando
    Urciuoli, Carolina
    Falcon, Florencia
    Paes de Lima, Andrea
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (02): : 157 - 163
  • [24] Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update
    Ciarallo, Anthony
    Rivera, Juan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (02) : 285 - 291
  • [25] Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German Population
    Eilsberger, Friederike
    Kreissl, Michael C.
    Reiners, Christoph
    Holzgreve, Adrien
    Luster, Markus
    Pfestroff, Andreas
    BIOMEDICINES, 2023, 11 (03)
  • [26] Limited Utility of Routine Surveillance Ultrasound in Differentiated Thyroid Cancer Patients With Undetectable Postoperative Thyroglobulin Levels
    Seo, Young-Ji
    Tiu, Ryan
    Stahl, Katharina
    Hughes, Elena
    Tseng, Chi-Hong
    Yeh, Michael
    Livhits, Masha
    Wu, James X.
    CLINICAL ENDOCRINOLOGY, 2025, : 600 - 606
  • [27] Role of thyroglobulin in the management of patients with differentiated thyroid cancer
    Seong Young Kwon
    Yingjie Zhang
    Yansong Lin
    Byeong-Cheol Ahn
    Hee-Seung Bom
    Clinical and Translational Imaging, 2019, 7 : 209 - 217
  • [28] Role of thyroglobulin in the management of patients with differentiated thyroid cancer
    Kwon, Seong Young
    Zhang, Yingjie
    Lin, Yansong
    Ahn, Byeong-Cheol
    Bom, Hee-Seung
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (03) : 209 - 217
  • [29] Controversies in the Management of Low-Risk Differentiated Thyroid Cancer
    Haymart, Megan R.
    Esfandiari, Nazanene H.
    Stang, Michael T.
    Sosa, Julia Ann
    ENDOCRINE REVIEWS, 2017, 38 (04) : 351 - 378
  • [30] Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors
    Russo, Marco
    Malandrino, Pasqualino
    Moleti, Mariacarla
    Vermiglio, Francesco
    D'Angelo, Antonio
    La Rosa, Giuliana
    Sapuppo, Giulia
    Calaciura, Francesca
    Regalbuto, Concetto
    Belfiore, Antonino
    Vigneri, Riccardo
    Pellegriti, Gabriella
    PEDIATRIC BLOOD & CANCER, 2018, 65 (09)